Ami Organics Limited signed another definitive agreement with Fermion. As part of the agreement, Ami Organics will manufacture couple of additional advanced pharmaceutical intermediates for Fermion. The two additional advanced pharmaceutical intermediates signed will be used in captive consumption for the manufacture of earlier advanced pharmaceutical intermediates signed with Fermion.

This agreement will lead to value addition to the final advanced intermediates which will be supplied by Ami Organics to Fermion, leading to higher value of end product. This will also help company become leading supplier of Fermion, supplying key advanced intermediates. The products are slated to be manufactured at the Ankleshwar Facility and is expected to start contributing meaningfully to the revenue from Financial Year 2025.

Ami Organics has already signed two agreements with Fermion in November 2022 and September 2023 for supply of two advanced pharmaceutical intermediates. This agreement is in addition to the previous agreements and further increases the total value of the CDMO contract with Fermion.